305 related articles for article (PubMed ID: 21554376)
1. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
[TBL] [Abstract][Full Text] [Related]
2. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
[TBL] [Abstract][Full Text] [Related]
3. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
4. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart.
Okazaki T; Otani H; Shimazu T; Yoshioka K; Fujita M; Katano T; Ito S; Iwasaka T
J Mol Cell Cardiol; 2011 Mar; 50(3):534-44. PubMed ID: 21182845
[TBL] [Abstract][Full Text] [Related]
5. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.
Pieper GM; Ionova IA; Cooley BC; Migrino RQ; Khanna AK; Whitsett J; Vásquez-Vivar J
J Pharmacol Exp Ther; 2009 Jun; 329(3):890-9. PubMed ID: 19307452
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart.
Okazaki T; Otani H; Shimazu T; Yoshioka K; Fujita M; Iwasaka T
Free Radic Res; 2011 Oct; 45(10):1173-83. PubMed ID: 21756052
[TBL] [Abstract][Full Text] [Related]
8. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
Yoshioka K; Otani H; Shimazu T; Fujita M; Iwasaka T; Shiojima I
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1782-91. PubMed ID: 26408540
[TBL] [Abstract][Full Text] [Related]
9. Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension.
Thida M; Earl J; Zhao Y; Wang H; Tse CS; Vickers JJ; Sutton M; Ong SL; Mori TA; Croft KD; Whitworth JA; Zhang Y
Am J Hypertens; 2010 May; 23(5):569-74. PubMed ID: 20186125
[TBL] [Abstract][Full Text] [Related]
10. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice.
Pannirselvam M; Simon V; Verma S; Anderson T; Triggle CR
Br J Pharmacol; 2003 Oct; 140(4):701-6. PubMed ID: 14534153
[TBL] [Abstract][Full Text] [Related]
11. BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes.
Carnicer R; Duglan D; Ziberna K; Recalde A; Reilly S; Simon JN; Mafrici S; Arya R; Roselló-Lletí E; Chuaiphichai S; Tyler D; Lygate CA; Channon KM; Casadei B
Circ Res; 2021 Mar; 128(5):585-601. PubMed ID: 33494625
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
13. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.
Sun Y; Carretero OA; Xu J; Rhaleb NE; Wang F; Lin C; Yang JJ; Pagano PJ; Yang XP
Hypertension; 2005 Dec; 46(6):1355-61. PubMed ID: 16286571
[TBL] [Abstract][Full Text] [Related]
14. Modulation of iNOS activity in age-related cardiac dysfunction.
Yang B; Larson DF; Watson RR
Life Sci; 2004 Jun; 75(6):655-67. PubMed ID: 15172175
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes.
Cheng X; Cheng XS; Kuo KH; Pang CC
Cardiovasc Res; 2004 Nov; 64(2):298-307. PubMed ID: 15485689
[TBL] [Abstract][Full Text] [Related]
16. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.
Liu YH; Carretero OA; Cingolani OH; Liao TD; Sun Y; Xu J; Li LY; Pagano PJ; Yang JJ; Yang XP
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2616-23. PubMed ID: 16055518
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.
Nagareddy PR; Xia Z; MacLeod KM; McNeill JH
J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064
[TBL] [Abstract][Full Text] [Related]
19. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
Nagareddy PR; McNeill JH; MacLeod KM
Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
Smith JM; Paulson DJ; Romano FD
J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
